Show ratings & reviews for

3.9 Overall Rating

Effectiveness

Ease of Use

Satisfaction

Most voted positive review

34 People found this comment helpful

I've been taking this, in conjunction with letrozole, for about 6 months. Only minor side effects from the letrozole. No progression on my stage IV metastatic breast cancer so far.

Most voted negative review

4 People found this comment helpful

Is this med for herz2 breast cancer?

Shared reviews and ratings

Anonymous | 65-74 | On medication for 6 months to less than 1 year | Patient
5/22/2016
Condition: Estrogen Receptor (ER)-Positive, HER2-Negative Postmenopausal Advanced Breast Cancer
Overall rating 5.0
Effectiveness
Ease of Use
Satisfaction
Report this postFill 3Created with Sketch.
Debby | 55-64 | On medication for 1 to 6 months | Patient
5/4/2016
Condition: Estrogen Receptor (ER)-Positive, HER2-Negative Postmenopausal Advanced Breast Cancer
Overall rating 4.0
Effectiveness
Ease of Use
Satisfaction

I have been taking Ibrance for 3 months with Faslodex and Xgeva for breast cancer metastasis. Side effects have been mild so far - mainly upset stomach, fatigue, hair loss. After 3 months the cancer markers are coming down.

Report this postFill 3Created with Sketch.
Nanda | 45-54 | On medication for 1 to 6 months | Patient
4/7/2016
Condition: Estrogen Receptor (ER)-Positive, HER2-Negative Postmenopausal Advanced Breast Cancer
Overall rating 5.0
Effectiveness
Ease of Use
Satisfaction

I have been on Ibrance with Exemestane for about 5 months now. It has been working, the lesion is stable. I haven't had any major side effects except for some mouth sores but no big deal.

Report this postFill 3Created with Sketch.
Anonymous | 55-64 | On medication for 2 to less than 5 years | Patient
3/15/2016
Condition: Estrogen Receptor (ER)-Positive, HER2-Negative Postmenopausal Advanced Breast Cancer
Overall rating 5.0
Effectiveness
Ease of Use
Satisfaction

I was part of the stage III study for this medication, for its FDA approval. Along with letrazole. It was very successful for me. Held back progression for 27 months. There are 3 dosages, 125,100

Report this postFill 3Created with Sketch.
Anonymous | 55-64 | On medication for 1 to 6 months | Patient
1/8/2016
Condition: Estrogen Receptor (ER)-Positive, HER2-Negative Postmenopausal Advanced Breast Cancer
Overall rating 3.0
Effectiveness
Ease of Use
Satisfaction

combo of Ibrance and Faslodex shots. Gagging and coughing are the worst side effects along with cramping from the shots. I can live with the drugs but the gagging and coughing are in my way. Tumor markers and scans stable after three cycles.

Report this postFill 3Created with Sketch.
Anonymous | 45-54 | Female | On medication for 6 months to less than 1 year | Patient
11/18/2015
Condition: Estrogen Receptor (ER)-Positive, HER2-Negative Postmenopausal Advanced Breast Cancer
Overall rating 4.3
Effectiveness
Ease of Use
Satisfaction

I've been taking this, in conjunction with letrozole, for about 6 months. Only minor side effects from the letrozole. No progression on my stage IV metastatic breast cancer so far.

Report this postFill 3Created with Sketch.
Anonymous | Female | On medication for less than 1 month | Patient
8/12/2015
Condition: Estrogen Receptor (ER)-Positive, HER2-Negative Postmenopausal Advanced Breast Cancer
Overall rating 2.3
Effectiveness
Ease of Use
Satisfaction

After one cycle horrible chest pains

Report this postFill 3Created with Sketch.
E | 75 or over | Female | On medication for less than 1 month | Patient
4/15/2015
Condition: Other
Overall rating 2.0
Effectiveness
Ease of Use
Satisfaction

Is this med for herz2 breast cancer?

Report this postFill 3Created with Sketch.

IMPORTANT INFORMATION ABOUT USER-GENERATED CONTENT ON WEBMD

The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, or blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions.

Read More